Physician profile
Charles Tanner
NPI 1740251016
$2,282.09
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $176 · 2021: $567 · 2022: $698 · 2023: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $698.43 | 2019-2023 | Xtandi, Myrbetriq |
| Abbvie INC. | $552.66 | 2019-2023 | Lupron Depot |
| Janssen Biotech, INC. | $362.19 | 2020-2023 | Erleada |
| Pfizer INC. | $234.55 | 2019-2023 | |
| Urovant Sciences INC | $108.64 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $80.57 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.12 | 2023 | |
| Teleflex LLC | $55.79 | 2021-2023 | Urolift |
| Kowa Pharmaceuticals America, INC. | $48.55 | 2023 | Seglentis |
| Antares Pharma, INC. | $31.48 | 2021-2023 | Xyosted, Tlando, Nocdurna |
| Blue Earth Diagnostics | $27.87 | 2021 | |
| Progenics Pharmaceuticals, INC. | $22.24 | 2023 | Pylarify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.